epiq scripts tirzepatide About AltRx | Trusted Online

Skin conditions at the injection site Never inject into skin that shows signs of damage or disease

This is exactly why people who inject too early experience amplified side effects, particularly nausea, which is already the most common side effect of GLP-1 receptor agonists

Retatrutide (GLP3) is a triple agonist adding glucagon for energy expenditure and fat burning, with phase 2/3 trials showing 2428.7% average weight loss over 4868 weekspotentially double semaglutides impact. What weight loss results have retatrutide shown in trials

Why retatrutide causes skin sensitivity The honest answer is that researchers do not fully understand the mechanism yet

Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations